These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 3079663

  • 1. Lymphokine-induced cytotoxicity: characterization of effectors, precursors, and regulatory ancillary cells.
    Ting CC, Yang SS, Hargrove ME.
    Cancer Res; 1986 Feb; 46(2):513-8. PubMed ID: 3079663
    [Abstract] [Full Text] [Related]

  • 2. Lymphokine-induced cytotoxicity: requirement of two lymphokines for the induction of optimal cytotoxic response.
    Yang SS, Malek TR, Hargrove ME, Ting CC.
    J Immunol; 1985 Jun; 134(6):3912-9. PubMed ID: 3921614
    [Abstract] [Full Text] [Related]

  • 3. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T, Belfrage H, Bhiladvala P, Hedlund G.
    J Immunol; 1987 Jun 01; 138(11):3640-5. PubMed ID: 3495566
    [Abstract] [Full Text] [Related]

  • 4. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
    Peace DJ, Kern DE, Schultz KR, Greenberg PD, Cheever MA.
    J Immunol; 1988 May 15; 140(10):3679-85. PubMed ID: 2896213
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneity of long-term cultured activated killer cells induced by anti-T3 antibody.
    Yun YS, Hargrove ME, Ting CC.
    J Immunol; 1988 Aug 15; 141(4):1390-7. PubMed ID: 3260924
    [Abstract] [Full Text] [Related]

  • 6. Differentiation of NK-like cells from OKT3-, OKT11+, and OKM1+ small resting lymphocytes by culture with autologous T cell blasts and lymphokine.
    Warren HS.
    J Immunol; 1984 Jun 15; 132(6):2888-94. PubMed ID: 6233364
    [Abstract] [Full Text] [Related]

  • 7. Lymphokine-activated killer (LAK) cells. II. Delineation of distinct murine LAK-precursor subpopulations.
    Ballas ZK, Rasmussen W, van Otegham JK.
    J Immunol; 1987 Mar 01; 138(5):1647-52. PubMed ID: 2879870
    [Abstract] [Full Text] [Related]

  • 8. Augmentation by anti-T3 antibody of the lymphokine-activated killer cell-mediated cytotoxicity.
    Ting CC, Hargrove ME, Yun YS.
    J Immunol; 1988 Aug 01; 141(3):741-8. PubMed ID: 3260909
    [Abstract] [Full Text] [Related]

  • 9. Activation of natural killer-derived cytotoxic T lymphocytes. I. Regulation by macrophage and prostaglandins.
    Ting CC, Hargrove ME.
    J Immunol; 1983 Oct 01; 131(4):1734-41. PubMed ID: 6604751
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J, Wisniewski D, Gulati S, Welte K, Knowles R, Clarkson B.
    Nat Immun Cell Growth Regul; 1987 Oct 01; 6(3):129-40. PubMed ID: 3114621
    [Abstract] [Full Text] [Related]

  • 11. Generation of cytotoxic cells from murine bone marrow by human recombinant IL 2.
    Koo GC, Manyak CL.
    J Immunol; 1986 Sep 15; 137(6):1751-6. PubMed ID: 2427580
    [Abstract] [Full Text] [Related]

  • 12. Lymphocyte-induced macrophage cytotoxicity. Production of specific macrophage arming factor by sensitized Lyt 1+2+ T-lymphocytes.
    Pels E, De Weger RA, Den Otter W.
    Int Arch Allergy Appl Immunol; 1984 Sep 15; 74(2):140-6. PubMed ID: 6609130
    [Abstract] [Full Text] [Related]

  • 13. Nonspecific cytotoxicity of vaccinia-induced peritoneal exudates in hamsters is mediated by Thy-1.2 homologue-positive cells distinct from NK cells and macrophages.
    Yang H, Tompkins WA.
    J Immunol; 1983 Nov 15; 131(5):2545-50. PubMed ID: 6195269
    [Abstract] [Full Text] [Related]

  • 14. Partially restorative role of T cells for low interleukin 2 dependent growth of NK cell progenitors from nude mice.
    Riccardi C, Migliorati G, Herberman RB.
    Nat Immun Cell Growth Regul; 1983 Nov 15; 3(1):7-21. PubMed ID: 6235449
    [Abstract] [Full Text] [Related]

  • 15. Precursor phenotype of lymphokine-activated killer cells in the mouse.
    Salup RR, Mathieson BJ, Wiltrout RH.
    J Immunol; 1987 Jun 01; 138(11):3635-9. PubMed ID: 3108370
    [Abstract] [Full Text] [Related]

  • 16. Detection and characterization of cytotoxic T lymphocyte precursors in the murine intestinal intraepithelial leukocyte population.
    Ernst PB, Clark DA, Rosenthal KL, Befus AD, Bienenstock J.
    J Immunol; 1986 Mar 15; 136(6):2121-6. PubMed ID: 2936822
    [Abstract] [Full Text] [Related]

  • 17. Lysis of human solid tumor cells by lymphokine-activated natural killer cells.
    Itoh K, Tilden AB, Balch CM.
    J Immunol; 1986 May 15; 136(10):3910-5. PubMed ID: 3084648
    [Abstract] [Full Text] [Related]

  • 18. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
    Kawase I, Komuta K, Hara H, Inoue T, Hosoe S, Ikeda T, Shirasaka T, Yokota S, Tanio Y, Masuno T.
    Cancer Res; 1988 Mar 01; 48(5):1173-9. PubMed ID: 3257715
    [Abstract] [Full Text] [Related]

  • 19. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA, Pedersen KF, Welsh RM.
    J Immunol; 1986 Jul 15; 137(2):463-71. PubMed ID: 3722814
    [Abstract] [Full Text] [Related]

  • 20. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
    Rosenstein M, Yron I, Kaufmann Y, Rosenberg SA.
    Cancer Res; 1984 May 15; 44(5):1946-53. PubMed ID: 6608989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.